NO20051082L - Antimikrobielle kinoloner, deres sammensetninger og anvendelser - Google Patents

Antimikrobielle kinoloner, deres sammensetninger og anvendelser

Info

Publication number
NO20051082L
NO20051082L NO20051082A NO20051082A NO20051082L NO 20051082 L NO20051082 L NO 20051082L NO 20051082 A NO20051082 A NO 20051082A NO 20051082 A NO20051082 A NO 20051082A NO 20051082 L NO20051082 L NO 20051082L
Authority
NO
Norway
Prior art keywords
compositions
applications
antimicrobial quinolones
quinolones
antimicrobial
Prior art date
Application number
NO20051082A
Other languages
English (en)
Norwegian (no)
Inventor
Benoit Ledoussal
Ji-In Kim Almstead
Jeffrey Lyle Gray
Xiufeng Eric Hu
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20051082L publication Critical patent/NO20051082L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20051082A 2002-07-31 2005-02-28 Antimikrobielle kinoloner, deres sammensetninger og anvendelser NO20051082L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40001402P 2002-07-31 2002-07-31
PCT/US2003/022587 WO2004014893A2 (fr) 2002-07-31 2003-07-18 Quinolones anti-microbiens, leurs compositions et utilisation

Publications (1)

Publication Number Publication Date
NO20051082L true NO20051082L (no) 2005-04-29

Family

ID=31715691

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051082A NO20051082L (no) 2002-07-31 2005-02-28 Antimikrobielle kinoloner, deres sammensetninger og anvendelser

Country Status (17)

Country Link
US (1) US6900224B2 (fr)
EP (1) EP1532137A2 (fr)
JP (1) JP2005536532A (fr)
KR (1) KR20050026074A (fr)
CN (1) CN1671690A (fr)
AU (1) AU2003259169A1 (fr)
BR (1) BR0313420A (fr)
CA (1) CA2493146A1 (fr)
IL (1) IL166041A0 (fr)
MA (1) MA27467A1 (fr)
MX (1) MXPA05001180A (fr)
NO (1) NO20051082L (fr)
NZ (1) NZ537203A (fr)
PL (1) PL375388A1 (fr)
RU (1) RU2005105337A (fr)
WO (1) WO2004014893A2 (fr)
ZA (1) ZA200500877B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK286420B6 (sk) * 1997-09-15 2008-09-05 The Procter & Gamble Company Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie
US20030125308A1 (en) * 1999-12-28 2003-07-03 Yukiko Inamoto Antipruritic agents for external use
US7354916B2 (en) * 2003-04-07 2008-04-08 Cylene Pharmaceuticals Substituted quinobenzoxazine analogs
US7507727B2 (en) * 2003-04-07 2009-03-24 Cylene Pharmaceuticals, Inc. Substituted quinobenzoxazine analogs and methods of using thereof
BRPI0409105A (pt) * 2003-04-07 2006-04-25 Cylene Pharmaceuticals Inc análogos de quinobenzoxazina substituìdos
WO2004091627A2 (fr) * 2003-04-07 2004-10-28 Cylene Pharmaceuticals, Inc. Analogues heterocycliques de 1,4-dihydro-4-oxo-1,8-naphthpyridine substitues
WO2006034113A2 (fr) * 2004-09-17 2006-03-30 Cylene Pharmaceuticals, Inc. Analogues de quinolone
US7652134B2 (en) * 2004-09-17 2010-01-26 Cylene Pharmaceuticals, Inc. Methods for converting quinolone esters into quinolone amides
CA2647457C (fr) * 2006-03-28 2011-05-24 The Procter & Gamble Company Procede de reduction par un hydrure servant a preparer des intermediaires de quinolones
EP2001862B1 (fr) * 2006-03-28 2011-04-27 Warner Chilcott Company, LLC Malates et formes polymorphes de l'acide (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinoleine-carboxylique
MX2008012488A (es) 2006-03-28 2008-10-10 Procter & Gamble Un proceso de acoplamiento para preparar intermedios de quinolona.
JP2010510317A (ja) * 2006-11-20 2010-04-02 ブリストル−マイヤーズ スクイブ カンパニー ジペプチジルペプチダーゼｉｖの阻害剤としての７，８−ジヒドロ−１，６−ナフチリジン−５（６ｈ）−オンおよび関連二環式化合物、および方法
US8658183B2 (en) * 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
US7928100B2 (en) 2007-10-05 2011-04-19 Cylene Pharmaceuticals, Inc. Quinolone analogs and methods related thereto
US8211909B2 (en) * 2008-07-01 2012-07-03 Taigen Biotechnology Co., Ltd. Treatment of antibiotic-resistant bacteria infection
CN101618039B (zh) * 2008-07-02 2012-04-11 太景生物科技股份有限公司 肺炎的治疗药物
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
NZ592831A (en) * 2008-12-15 2013-06-28 Taigen Biotechnology Co Ltd Stereoselective synthesis of piperidine derivatives
CN102093260B (zh) * 2009-12-14 2014-03-05 太景生物科技股份有限公司 哌啶衍生物的立体有择合成
JP7017509B2 (ja) 2015-11-20 2022-02-08 センワ バイオサイエンシズ インコーポレイテッド がんを治療するための四環式キノロン類似体の併用療法
US9957282B2 (en) 2015-12-14 2018-05-01 Senhwa Biosciences, Inc. Crystalline forms of quinolone analogs and their salts
WO2017107089A1 (fr) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. Modulateurs allostériques 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine
TW201726675A (zh) 2015-12-23 2017-08-01 默沙東藥廠 M4毒蕈鹼乙醯膽鹼受體之異位調節劑6,7-二氫-5h-吡咯并[3,4-b]吡啶-5-酮
WO2018112843A1 (fr) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Modulateurs allostériques d'éther hétéroarylpipéridine du récepteur muscarinique de l'acétylcholine m4
WO2018112840A1 (fr) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Modulateurs allostériques d'éther d'hétéroarylpipéridine 6, 5-fusionnés du récepteur muscarinique d'acétylcholine m4
WO2018112842A1 (fr) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Modulateurs allostériques d'éther hétéroarylpipéridine 6,6-fusionné du récepteur muscarinique de l'acétylcholine m4
WO2019000237A1 (fr) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. Modulateurs allostériques de 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine
WO2019000236A1 (fr) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. Modulateurs allostériques de 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine
WO2019000238A1 (fr) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. Modulateurs allostériques de 5-(pyridin-3-yl)oxazole du récepteur muscarinique m4 de l'acétylcholine
CN112334133A (zh) 2018-02-15 2021-02-05 生华生物科技股份有限公司 喹诺酮类似物及其盐、组合物及其使用方法
JP7410050B2 (ja) * 2018-04-25 2024-01-09 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング キノロンカルボン酸エステルの加水分解プロセス

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340285C (fr) 1988-05-19 1998-12-22 Hiroyuki Nagano Derives d'acide quinolonecarboxylique avec, en position 7, un substituant piperidin-1-ylique
EP0723545B1 (fr) * 1993-10-14 2002-05-08 Abbott Laboratories Composes du type de la quinolizinone
KR19990022524A (ko) * 1995-06-06 1999-03-25 웨인스톡 스티븐 에프. 퀴놀리지논형화합물
KR100241673B1 (ko) * 1997-08-09 2000-03-02 김충섭 퀴놀리진 카르복실산 유도체
SK286420B6 (sk) * 1997-09-15 2008-09-05 The Procter & Gamble Company Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9914486D0 (en) 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
SK10572002A3 (sk) * 2000-01-24 2003-10-07 Warner-Lambert Company 3-Aminochinazolín-2,4-diónové antibakteriálne činidlá
ATE304539T1 (de) 2000-12-14 2005-09-15 Procter & Gamble Antimikrobielle chinolone

Also Published As

Publication number Publication date
PL375388A1 (en) 2005-11-28
US6900224B2 (en) 2005-05-31
US20040038975A1 (en) 2004-02-26
WO2004014893A2 (fr) 2004-02-19
EP1532137A2 (fr) 2005-05-25
CN1671690A (zh) 2005-09-21
MA27467A1 (fr) 2005-08-01
RU2005105337A (ru) 2006-01-20
ZA200500877B (en) 2006-02-20
CA2493146A1 (fr) 2004-02-19
MXPA05001180A (es) 2005-05-16
IL166041A0 (en) 2006-01-15
JP2005536532A (ja) 2005-12-02
BR0313420A (pt) 2005-06-28
KR20050026074A (ko) 2005-03-14
WO2004014893A3 (fr) 2004-04-08
AU2003259169A1 (en) 2004-02-25
NZ537203A (en) 2007-02-23

Similar Documents

Publication Publication Date Title
NO20051082L (no) Antimikrobielle kinoloner, deres sammensetninger og anvendelser
IS7721A (is) Píperidín-pýrídasón og þalasón sem PDE4 hemlar
NO20052787D0 (no) N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
NO20062892L (no) 7-fenylalkyl-substituert 2-kinolinoner og 2-kinoksalinoner som poly(adp-ribose)-polymeraseinhibitorer
EP1560556A4 (fr) Compositions antimicrobiennes
SE0102315D0 (sv) Compounds
NO20044995L (no) Heterosykliske forbindelser
ATE413388T1 (de) Muskarin antagonisten
DK1432705T3 (da) Antibiotika med dobbeltvirkning
DK1531672T3 (da) Antimikrobielle sammensætninger
DK1709044T3 (da) Oxazolidinon-quinolon-hybridantibiotika
NO20080265L (no) 2-(1H-indolylsulfanyl)-arylaminderivater
NO20064415L (no) Nye amido-substituerte hydroksy-6-fenylfenantridiner og deres anvendelse som PDE4-inhibitorer
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
ATE397861T1 (de) Synergistische zusammensetzungen
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
DK1095059T3 (da) Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse
NO20030500D0 (no) Dihydroporfyrinderivater og deres anvendelse
BR0313400A (pt) N-aril-2-oxazolidinonas e seus derivados
DK1648906T3 (da) Organo-silicium-forbindelser og deres anvendelse
ATE348803T1 (de) Tryptase-inhibitoren
HN2002000111A (es) Agentes antibacterianos
NO20053562L (no) Nye aminobenzofenonforbindelser
ATE364037T1 (de) Tryptasehemmer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application